Clinical Trial Update: Bevacizumab and Erlotinib in Treating Patients With Advanced Liver Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update shows completion and results posting for bevacizumab plus erlotinib in adults with hepatocellular carcinoma. The study encompassed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• ERLOTINIB (Erlotinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-07-10